EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A novel eye‐tracking digital marker outperforms plasma biomarkers in detecting cognitive impairment

Yi Ling, Pan Sun, Chen Wang, Guoping Peng, Yiying Wang, Xin Zhou, Zhengbo He, Binhui Liu, Jie Zhang, Jie Yu, Yujie Su, Kai Li und 2 weitere

Alzheimer's & Dementia · 2026

DOI: 10.1002/alz.71253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Yi Ling und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Biomarkers, Cognitive Dysfunction, Eye-Tracking Technology. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Key Research and Development Program of Zhejiang, the Fundamental Research for the Central Universities, Medical and Health Science and Technology Project of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Detecting and monitoring cognitive performance in older adults is critical. In this study, we evaluated the validity of an eye‐tracking tool in diagnosing cognitive impairment. METHODS We recruited 119 cognitively unimpaired (CU) individuals and 157 cognitively impaired (CI) patients who completed digital eye‐tracking tests and cognitive scales. Of them, 154, 120, 53, and 146 underwent plasma biomarker tests, amyloid‐β positron emission tomography (Aβ‐PET) scans, tau‐PET scans, and magnetic resonance imaging (MRI) scans. The diagnostic performance of eye‐tracking markers and their relationships to Alzheimer's disease biomarkers and cognition were examined. RESULTS The eye‐tracking panel exhibited better performance (area under the curve [AUC] = 0.865) in classifying CI from CU compared to plasma Aβ 42/40 (AUC = 0.699), p‐Tau 217 (AUC = 0.769), p‐Tau 217 /Aβ 42 (AUC = 0.801), glial fibrillary acidic protein (GFAP; AUC = 0.804), and neurofilament light chain (NfL) (AUC = 0.826). DISCUSSION These findings demonstrate the validity of digital eye‐tracking markers for screening patients with cognitive impairment, providing a novel digital marker for detecting cognitive decline in older adults.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersCognitive DysfunctionEye-Tracking TechnologyHumansFemaleAgedMaleAmyloid beta-Peptidestau ProteinsPositron-Emission TomographyMagnetic Resonance ImagingNeuropsychological TestsPeptide FragmentsAged, 80 and over

Stichwörter der Autor:innen

Alzheimer's diseasecognitive impairmentdigital biomarkereye‐trackingplasma biomarker

Substanzen

BiomarkersAmyloid beta-Peptidestau ProteinsPeptide Fragments

Autor:innen und Institutionen

  • Department of Neurology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Institute of Neurological and Psychiatric Disorders, Shenzhen Bay Laboratory, Shenzhen, China.
  • School of Information Engineering, Hangzhou Medical College, Hangzhou, China.
  • Zhejiang Engineering Research Center for Brain Cognition and Brain Diseases Digital Medical Instruments, Hangzhou Medical College, Hangzhou, China.
  • Center for Rehabilitation Medicine, Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, Department of Rehabilitation Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital),…
  • The MOE Frontier Science Center for Brain Science and Brain-Machine Integration, Zhejiang University, Hangzhou, China.

ORCID-Profile: Tengfei Guo

Förderung

  • the Key Research and Development Program of Zhejiang
  • the Fundamental Research for the Central Universities
  • Medical and Health Science and Technology Project of Zhejiang Province
  • the National Natural Science Foundation of China
  • Guangdong Basic and Applied Basic Science Foundation for Distinguished Young Scholars

Zitieren

APA

Ling, Y., Sun, P., Wang, C., Peng, G., Wang, Y., Zhou, X., He, Z., Liu, B., Zhang, J., Yu, J., Su, Y., Li, K., Guo, T., & Luo, B. (2026). A novel eye‐tracking digital marker outperforms plasma biomarkers in detecting cognitive impairment. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71253

Vancouver

Ling Y, Sun P, Wang C, Peng G, Wang Y, Zhou X, et al. A novel eye‐tracking digital marker outperforms plasma biomarkers in detecting cognitive impairment. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71253

BibTeX
@article{Ling2026,
  author = {Ling, Yi and Sun, Pan and Wang, Chen and Peng, Guoping and Wang, Yiying and Zhou, Xin and He, Zhengbo and Liu, Binhui and Zhang, Jie and Yu, Jie and Su, Yujie and Li, Kai and Guo, Tengfei and Luo, Benyan},
  title = {A novel eye‐tracking digital marker outperforms plasma biomarkers in detecting cognitive impairment},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  doi = {10.1002/alz.71253}
}
Kostenlos starten →